Nature Communications

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

2025-05-15

Full text

DOI https://doi.org/10.1038/s41467-025-59810-2